Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for MGRX is 7.13M, and currently, short sellers hold a 1.69% ratio of that floaft. The average trading volume of MGRX on November 20, 2023 was 256.24K shares.
MGRX) stock’s latest price update
The stock of Mangoceuticals Inc (NASDAQ: MGRX) has increased by 16.94 when compared to last closing price of 0.43.Despite this, the company has seen a gain of 11.82% in its stock price over the last five trading days. Market Watch reported 2023-06-09 that Shares of Mangoceuticals Inc. MGRX, +10.81% fell 6.7% in premarket trading, to extend their sharp pullback from the previous session’s intraday high. The stock had rocketed as much as 60.8% to an intraday high of $2.38 soon after Thursday’s open, but closed up just 10.8%, after the erectile dysfunction (ED) drug maker announced a sponsorship deal with Barstool Sports.
MGRX’s Market Performance
Mangoceuticals Inc (MGRX) has seen a 11.82% rise in stock performance for the week, with a -40.80% decline in the past month and a -55.86% plunge in the past quarter. The volatility ratio for the week is 13.77%, and the volatility levels for the past 30 days are at 15.18% for MGRX. The simple moving average for the past 20 days is -20.15% for MGRX’s stock, with a -58.40% simple moving average for the past 200 days.
MGRX Trading at -33.01% from the 50-Day Moving Average
After a stumble in the market that brought MGRX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -88.49% of loss for the given period.
Volatility was left at 15.18%, however, over the last 30 days, the volatility rate increased by 13.77%, as shares sank -48.00% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -57.71% lower at present.
During the last 5 trading sessions, MGRX rose by +11.82%, in comparison to the 20-day moving average, which settled at $0.6070. In addition, Mangoceuticals Inc saw -87.42% in overturn over a single year, with a tendency to cut further losses.
Reports are indicating that there were more than several insider trading activities at MGRX starting from Cohen Jacob D., who purchase 275,000 shares at the price of $1.00 back on Apr 10. After this action, Cohen Jacob D. now owns 8,275,000 shares of Mangoceuticals Inc, valued at $275,000 using the latest closing price.
Stock Fundamentals for MGRX
Current profitability levels for the company are sitting at:
- -22279.70 for the present operating margin
- +54.26 for the gross margin
The net margin for Mangoceuticals Inc stands at -22352.11. The total capital return value is set at -402.57, while invested capital returns managed to touch -550.44.
Based on Mangoceuticals Inc (MGRX), the company’s capital structure generated 57.47 points at debt to equity in total, while total debt to capital is 36.49. Total debt to assets is 35.17, with long-term debt to equity ratio resting at 20.96. Finally, the long-term debt to capital ratio is 13.31.
The liquidity ratio also appears to be rather interesting for investors as it stands at 2.67.
In a nutshell, Mangoceuticals Inc (MGRX) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.